Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
302.69
+12.15 (4.18%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $8.70 billion as of April 24, 2025. Its market cap has decreased by -30.80% in one year.
Market Cap
8.70B
Enterprise Value
8.41B
1-Year Change
-30.80%
Ranking
Category
Stock Price
$302.69
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $8.70B, an increase of 689.67%. That is a compound annual growth rate of 26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 8.35B | -19.13% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.94B |
| UnitedHealth Group | 395.04B |
| Johnson & Johnson | 373.79B |
| AbbVie | 310.77B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.21B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |